BILLERICA, Mass., Jan. 3, 2017 /PRNewswire/ -- Bruker
Corporation (NASDAQ: BRKR) announced today it will present at the
35th annual J.P. Morgan Healthcare Conference in
San Francisco. Frank Laukien, Chairman, President & CEO and
Tony Mattacchione, Senior Vice
President and CFO will present on behalf of the company on
Monday, January 9th, 2017
at 8:00 AM Pacific Time.
A live audio webcast of the presentation will be available on
the Investor section of the Company's Web site at
http://ir.bruker.com. A replay of the presentation will be posted
on the Bruker Corporation website after the event and will be
available for 30 days following the presentation.
About Bruker Corporation
For more than 50 years, Bruker has enabled scientists to make
breakthrough discoveries and develop new applications that improve
the quality of human life. Bruker's high-performance
scientific research instruments and high-value analytical solutions
enable scientists to explore life and materials at molecular,
cellular and microscopic levels.
In close cooperation with our customers, Bruker is enabling
innovation, productivity and customer success in life science
molecular research, in applied and pharma applications, and in
microscopy, nano-analysis and industrial applications, as well as
in cell biology, preclinical imaging, clinical research,
microbiology and molecular diagnostics. For more information,
please visit: http://www.bruker.com.
Contact:
Miroslava
Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/bruker-corporation-to-present-at-the-35th-annual-jp-morgan-healthcare-conference-300384750.html
SOURCE Bruker Corporation